论文部分内容阅读
目的研究分析康复新液治疗口腔正畸患儿慢性龈炎的临床效果。方法 98例接受慢性龈炎治疗的口腔正畸患儿,按治疗先后顺序分为康复新液组和牙周洁治组,每组49例。康复新液组患儿在龈上洁治术治疗的基础上采用康复新液治疗,牙周洁治组患儿采用龈上洁治术治疗。对比两组患儿采用不同治疗方式治疗的效果。结果康复新液组治疗前牙龈指数(GI)(2.19±0.61)分,治疗后GI(0.78±0.52)分;牙周洁治组治疗前GI(2.21±0.34)分,治疗后GI(1.06±0.45)分;两组患儿治疗前GI比较差异无统计学意义(P>0.05),治疗后两组GI均较治疗前降低,且康复新液组低于牙周洁治组,差异均具有统计学意义(P<0.05)。康复新液组治疗前菌斑指数(PLI)(2.67±0.45)分,治疗后PLI(0.45±0.38)分;牙周洁治组治疗前PLI(2.38±0.55)分,治疗后PLI(1.11±0.21)分;两组患儿治疗前PLI比较差异无统计学意义(P>0.05),治疗后两组PLI均较治疗前降低,且康复新液组低于牙周洁治组,差异均具有统计学意义(P<0.05)。结论康复新液是治疗口腔正畸患儿慢性龈炎的首选药物之一,该药治疗的效果明显、安全可靠,值得在临床上推广和应用。
Objective To study the clinical effect of Kangfuxin Solution on chronic gingivitis in children with orthodontics. Methods A total of 98 children with orthodontics treated with chronic gingivitis were divided into Kangfuxinye group and JZG group according to the order of treatment, 49 cases in each group. Kangfuxin liquid group was treated with Kangfuxinye on the basis of supragingival neoplasm treatment, while the patients in Jiedujieji group were treated with supragingival cleanup. Comparison of two groups of children treated with different effects of treatment. Results The Gingival Index (GI) (2.19 ± 0.61) before treatment and the GI after treatment (0.78 ± 0.52) before treatment in KFNF group were significantly lower than those before GGT (2.21 ± 0.34) and GI (1.06 ± 0.45) There was no significant difference in GI between the two groups before treatment (P> 0.05). After treatment, both groups of GI decreased compared with those before treatment, and the recovery group was lower than that of periodontal treatment group (P> 0.05), the difference was statistically significant P <0.05). The PLI (2.67 ± 0.45) points before treatment and the PLI after treatment (0.45 ± 0.38) in PLFX group were significantly higher than that in PLF group (2.38 ± 0.55% vs 1.11 ± 0.21% There was no significant difference in PLI between the two groups before treatment (P> 0.05). After treatment, the PLI of both groups was lower than that before treatment, and the recovery group was lower than that of periodontal treatment group (P> 0.05) P <0.05). Conclusion Kangfuxin solution is one of the most preferred drugs for the treatment of chronic gingivitis in children with orthodontics. The drug is effective and safe, which is worthy of clinical application and promotion.